Patient Guide: A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 126 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06615479
Status: 🟢 Enrolling Now
Condition: Relapsed or Refractory Multiple Myeloma (RRMM)
Phase: PHASE3

Where You Can Participate

This study is available at 126 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Los Angeles, California
  • • Miami, Florida
  • • And 123 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) - Join Clinical Trial NCTNCT06615479

How to Join This Clinical Trial - NCTNCT06615479

Learn how to participate in this PHASE3 trial studying an investigational therapy for Relapsed or Refractory Multiple Myeloma (RRMM). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsed or Refractory Multiple Myeloma (RRMM). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsed or Refractory Multiple Myeloma (RRMM)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06615479 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 126 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35205 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Los Angeles, California 90404 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33136 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02118 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Charlotte, North Carolina 28204 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Winston-Salem, North Carolina 27157 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19111 - United States

Status: RECRUITING

Clinical Research Site

Salt Lake City, Utah 84112 - United States

Status: NOT_YET_RECRUITING

And 116 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Relapsed or Refractory Multiple Myeloma (RRMM):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships